Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Injectable Cement Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The injectable cement market has shown strong growth over recent years. It is projected to increase in value from $1.55 billion in 2025 to $1.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. Historically, this expansion has been driven by factors including the increasing prevalence of bone fractures, the ongoing reliance on traditional orthopedic fixation methods, the expanding elderly population, the growth of hospital-based orthopedic care, and the adoption of PMMA-based bone cements.
The injectable cement market size is projected to experience robust growth in the coming years. It is anticipated to expand to $2.13 billion in 2030, driven by a compound annual growth rate (CAGR) of 6.4%. This growth over the forecast period is attributable to technological advancements in injectable cement formulations, increasing demand for minimally invasive surgeries, a rise in orthopedic trauma cases, the expansion of outpatient and clinic-based procedures, and a greater emphasis on biocompatible and bioactive materials. Significant trends during this period include the growing adoption of minimally invasive orthopedic procedures, the wider use of injectable cement in fracture stabilization, an increasing preference for image-guided cement injection, innovations in bioactive and composite injectable cements, and an improved focus on faster recovery and overall patient outcomes.
Get A Free Sample Report With In-Depth Market Insights:
Injectable Cement Market Growth Factors Behind Sustained Expansion
The increasing prevalence of sports-related injuries is projected to drive the expansion of the injectable cement market in the foreseeable future. Sports-related injuries are physical damages sustained during athletic pursuits, encompassing strains, sprains, fractures, and concussions, frequently necessitating medical intervention and rehabilitation for recovery. The rise in these injuries is likely attributed to heightened participation in athletic activities, more rigorous training regimens, and advancements in sports equipment that push physical boundaries, leading to elevated injury rates among athletes worldwide. Injectable cement is utilized in the treatment of sports-related injuries to stabilize fractures, support bone healing, and enhance surgical outcomes by offering a reliable and minimally invasive solution for bone reinforcement. For instance, in July 2025, according to the Australian Institute of Health and Welfare, a government agency based in Australia, cycling registered the largest share of sports-related hospitalizations in 2023–24, accounting for 12% (around 7,500 cases). This was followed by Australian rules football at 8.7% (about 5,400 cases) and soccer at 8.6% (roughly 5,300 cases). Therefore, the increasing number of sports-related injuries will stimulate the growth of the injectable cement market.
Injectable Cement Market Segment Breakdown: Which Categories Lead On Revenue?
The injectable cement market covered in this report is segmented –
1) By Type: High Viscosity Cement, Low Viscosity Cement, Medium Viscosity Cement
2) By Application: Periprosthetic Fractures, Pelvic Fractures, Other Applications
3) By End User: Hospital, Clinics, Other End Users
Subsegments:
1) By High Viscosity Cement: Calcium Phosphate Cements, Polymethyl Methacrylate (PMMA) Cements
2) By Low Viscosity Cement: Acrylic-Based Injectable Cements, Bioactive Glass Cements
3) By Medium Viscosity Cement: Hybrid Injectable Cements, Composite Injectable Cements
Injectable Cement Market Industry Trends Fueling Future Revenue Growth
Key players in the injectable cement market are prioritizing technological advancements, notably antibiotic-loaded bone cement, to enhance infection prevention, improve patient recovery, and support more precise and effective interventions during orthopedic surgeries. Antibiotic-loaded bone cement is a specialized type of bone cement that incorporates antibiotics directly into its material, aimed at preventing or treating infections at the operative site, particularly in orthopedic procedures. As an illustration, in April 2024, Heraeus Medical GmbH, a medical technology manufacturer based in Germany, launched COPAL G+C, its latest antibiotic-loaded bone cement. This product is the company’s inaugural offering to achieve certification under the MDR. COPAL G+C contains both gentamicin and clindamycin, enabling focused infection management in arthroplasty by addressing up to 90% of pathogens commonly associated with prosthetic joint infections.
Injectable Cement Market Top Companies Driving Competitive Growth
Major companies operating in the injectable cement market are Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, Smith & Nephew, Arthrex Inc, Enovis Corporation, Globus Medical Inc, Wright Medical Group N.V, Medacta International, Orthofix Medical Inc, Alphatec Spine Inc, Exactech Inc, Spine Wave Inc, Tecres SpA, Heraeus Medical GmbH, TEKNIMED, Graftys SA, Solco Biomedical, Terumo Corporation, Bonesupport AB, Peregrine Biologics, aap Implantate AG, Biometrix Ltd, OSARTIS GmbH, IZI Medical
View The Full Injectable Cement Market Report:
Injectable Cement Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the injectable cement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable cement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
